Frank Brosens's Net Worth

$0

Estimate Recalculated Sep 12, 2024 04:04PM EST

Who is Frank Brosens

Frank Brosens does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORNER GROWTH ACQUISITION CORP. 2, InFinT Acquisition Corp, Prime Impact Acquisition I, Molecular Insight Pharmaceuticals, Inc., and Churchill Capital Corp VI.

SEC CIK

Frank Brosens's CIK is 0001048891

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CORNER GROWTH ACQUISITION CORP. 2

Investor
Updated Nov 07, 2023
Form 4
-33.14%
-300.00K
$11.20
-$3.36M
Nov 07, 2023
605.16K
Sale
Nov 03
Form 3
Aug 04, 2022
905.16K
Showing 2 results

InFinT Acquisition Corp

Investor
Updated Aug 24, 2023
Form 4
-40.67%
-305.00K
$11.01
-$3.36M
Aug 24, 2023
445.00K
Sale
Aug 22
Form 3
Aug 24, 2023
750.00K
Form 4
-40.00%
-500.00K
$10.92
-$5.46M
Aug 04, 2023
750.00K
Sale
Aug 02
Form 3
Mar 29, 2023
1.25M
Showing 4 results

Prime Impact Acquisition I

Investor
Updated Sep 19, 2023
Form 4
-100.00%
-700.00K
$10.82
-$7.57M
Sep 19, 2023
Disposition
Sep 08
Form 3
Oct 07, 2022
700.00K
Showing 2 results

Molecular Insight Pharmaceuticals, Inc.

Investor
Updated Jul 01, 2010
Form 3
Jul 01, 2010
Showing 1 results

Churchill Capital Corp VI

Investor
Updated Sep 29, 2023
Form 4
-15.95%
-500.00K
$10.46
-$5.23M
Sep 29, 2023
2.63M
Sale
Sep 28
Form 4
-14.35%
-525.00K
$10.40
-$5.46M
Aug 17, 2023
3.13M
Sale
Aug 15
Form 3
Aug 17, 2023
3.13M
Showing 3 results